Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-01 Sale | 2024-10-02 4:31 pm | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $10.11 | $101,052 | 11,286 (Direct) | View |
| 2024-09-03 Sale | 2024-09-04 8:20 pm | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $11.56 | $115,588 | 21,286 (Direct) | View |
| 2024-08-01 Sale | 2024-08-05 6:39 pm | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,100 | $13.51 | $136,454 | 32,686 (Direct) | View |
| 2024-08-01 Sale | 2024-08-05 6:39 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 100 | $15 | $1,500 | 170,037 (Direct) | View |
| 2024-07-29 Sale | 2024-07-30 5:01 pm | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 11,000 | $15.04 | $165,495 | 12,786 (Direct) | View |
| 2024-07-29 Sale | 2024-07-30 5:01 pm | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 9,648 | $15.04 | $145,106 | 170,137 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 5:00 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 27,590 | $13.88 | $382,934 | 526,112 (Direct) | View |
| 2024-07-16 Sale | 2024-07-18 5:05 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 2,410 | $13.77 | $33,192 | 568,133 (Direct) | View |
| 2024-07-01 Sale | 2024-07-03 07:55 am | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $11.27 | $112,691 | 41,286 (Direct) | View |
| 2024-05-14 Sale | 2024-05-16 5:06 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $15.81 | $237,222 | 489,389 (Direct) | View |
| 2024-04-15 Sale | 2024-04-17 5:05 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $18.19 | $272,871 | 504,389 (Direct) | View |
| 2024-03-14 Sale | 2024-03-18 5:03 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $21.86 | $327,942 | 519,389 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 6:05 pm | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 12,878 | $28.36 | $365,220 | 138,469 (Direct) | View |
| 2024-02-14 Sale | 2024-02-16 6:28 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $16.76 | $251,349 | 534,389 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 6:39 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $15.18 | $682,992 | 549,389 (Direct) | View |
| 2024-01-03 Sale | 2024-01-04 4:23 pm | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 17,237 | $17.39 | $299,789 | 158,067 (Direct) | View |
| 2023-12-19 Sale | 2023-12-21 1:38 pm | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $19.68 | $885,825 | 577,959 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-01 Exercise | 2024-10-02 4:31 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $0 | 11,286 (Direct) | View |
| 2024-10-01 Exercise | 2024-10-02 4:31 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $3.76 | 11,286 (Direct) | View |
| 2024-09-16 Option Award | 2024-09-18 5:04 pm | N/A 2034-09-16 | REGENXBIO Inc. | RGNX | Chan Mitchell Chief Financial Officer | 348,231 | $0 | 348,231 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-04 8:20 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $0 | 21,286 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-04 8:20 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $3.76 | 21,286 (Direct) | View |
| 2024-08-08 Exercise | 2024-08-12 4:58 pm | N/A 2024-09-24 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 36,316 | $0 | 444,351 (Direct) | View |
| 2024-08-08 Exercise | 2024-08-12 4:58 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 36,316 | $0.85 | 444,351 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 6:41 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 58,386 | $0 | 165,578 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 6:39 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 56,446 | $0 | 172,205 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 6:39 pm | N/A 2026-06-01 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,100 | $0 | 32,686 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 6:39 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 100 | $12.74 | 32,686 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 6:39 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $3.76 | 32,686 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 6:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 58,867 | $0 | 185,083 (Direct) | View |
| 2024-06-28 Option Award | 2024-08-05 6:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 1,363 | $9.945 | 185,083 (Direct) | View |
| 2024-07-29 Exercise | 2024-07-30 5:01 pm | N/A 2026-06-01 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 11,000 | $0 | 12,786 (Direct) | View |
| 2024-07-29 Exercise | 2024-07-30 5:01 pm | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 11,000 | $12.74 | 12,786 (Direct) | View |
| 2024-07-24 Exercise | 2024-07-26 5:00 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 27,590 | $0 | 526,112 (Direct) | View |
| 2024-07-24 Exercise | 2024-07-26 5:00 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 27,590 | $3.76 | 526,112 (Direct) | View |
| 2024-07-16 Exercise | 2024-07-18 5:05 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 2,410 | $0 | 568,133 (Direct) | View |
| 2024-07-16 Exercise | 2024-07-18 5:05 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. Director | 2,410 | $3.76 | 568,133 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 07:56 am | N/A 2034-07-01 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Executive Officer | 328,647 | $0 | 451,974 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-03 07:55 am | N/A 2025-05-18 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $0 | 41,286 (Direct) | View |
| 2024-07-01 Exercise | 2024-07-03 07:55 am | N/A N/A | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 10,000 | $3.76 | 41,286 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:43 pm | N/A 2034-05-31 | REGENXBIO Inc. | RGNX | Zachary Jennifer Director | 29,244 | $0 | 38,750 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:43 pm | N/A 2034-05-31 | REGENXBIO Inc. | RGNX | MIGAUSKY GEORGE V Director | 29,244 | $0 | 35,740 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:42 pm | N/A 2034-05-31 | REGENXBIO Inc. | RGNX | KARABELAS ARGERIS N Director | 29,244 | $0 | 35,740 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:42 pm | N/A 2034-05-31 | REGENXBIO Inc. | RGNX | Glucksmann Alexandra Director | 29,244 | $0 | 35,740 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:41 pm | N/A 2034-05-31 | REGENXBIO Inc. | RGNX | Bennett Jean Director | 29,244 | $0 | 35,740 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:41 pm | N/A 2034-05-31 | REGENXBIO Inc. | RGNX | Fox Allan M. Director | 29,244 | $0 | 2,918,206 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:40 pm | N/A 2034-05-31 | REGENXBIO Inc. | RGNX | Tasse Daniel Director | 29,244 | $0 | 35,740 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:39 pm | N/A 2034-05-31 | REGENXBIO Inc. | RGNX | STUMP DAVID C Director | 29,244 | $0 | 35,740 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 5:06 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $0 | 489,389 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 5:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $3.76 | 489,389 (Direct) | View |
| 2024-04-15 Exercise | 2024-04-17 5:05 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $0 | 504,389 (Direct) | View |
| 2024-04-15 Exercise | 2024-04-17 5:05 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $3.76 | 504,389 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-21 5:20 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 20,041 | $0 | 246,534 (Direct) | View |
| 2024-03-19 Exercise | 2024-03-21 5:20 pm | N/A N/A | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 20,041 | $3.76 | 246,534 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-18 5:03 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $0 | 519,389 (Direct) | View |
| 2024-03-14 Exercise | 2024-03-18 5:03 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $3.76 | 519,389 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 6:05 pm | N/A 2033-01-03 | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 12,878 | $0 | 138,469 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-07 6:05 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 12,878 | $22.25 | 138,469 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 6:28 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $0 | 534,389 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 6:28 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 15,000 | $3.76 | 534,389 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:39 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $0 | 549,389 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-18 6:39 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $3.76 | 549,389 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:34 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 99,512 | $0 | 184,377 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:34 pm | N/A N/A | REGENXBIO Inc. | RGNX | Simpson Curran Chief Oper. & Tech. Officer | 8,120 | $17.95 | 184,377 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:23 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 82,926 | $0 | 158,067 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:23 pm | N/A N/A | REGENXBIO Inc. | RGNX | PAKOLA STEVE Chief Medical Officer | 10,385 | $17.95 | 158,067 (Direct) | View |
| 2022-06-30 Option Award | 2024-01-04 4:22 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 728 | $21 | 185,903 (Direct) | View |
| 2023-06-30 Option Award | 2024-01-04 4:22 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 1,123 | $16.99 | 185,903 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:22 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 99,512 | $0 | 185,903 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:22 pm | N/A N/A | REGENXBIO Inc. | RGNX | Danos Olivier Chief Scientific Officer | 8,410 | $17.95 | 185,903 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:17 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 92,339 | $0 | 302,806 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:17 pm | N/A N/A | REGENXBIO Inc. | RGNX | Vasista Vittal Chief Financial Officer | 4,534 | $17.95 | 302,806 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:07 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 369,353 | $0 | 713,285 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:07 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 11,357 | $17.95 | 713,285 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:06 pm | N/A 2034-01-02 | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 89,560 | $0 | 170,704 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-04 4:06 pm | N/A N/A | REGENXBIO Inc. | RGNX | Christmas Patrick J. Chief Legal Officer | 7,893 | $17.95 | 170,704 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 1:38 pm | N/A 2025-05-19 | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 45,000 | $0 | 577,959 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 1:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 1,500 | $0.85 | 577,959 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 1:38 pm | N/A N/A | REGENXBIO Inc. | RGNX | Mills Kenneth T. President and CEO | 43,500 | $3.76 | 577,959 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:14 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | Fox Allan M. Director | 21,378 | $0 | 2,906,854 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 5:13 pm | N/A 2033-06-02 | REGENXBIO Inc. | RGNX | Tasse Daniel Director | 21,378 | $0 | 24,388 (Direct) | View |